Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Oncopeptides Major Shareholding Notification 2019

Jan 30, 2019

3091_iss_2019-01-30_06385ef1-7158-4101-828e-061cf59c4488.pdf

Major Shareholding Notification

Open in viewer

Opens in your device viewer

Issuer Oncopeptides AB

Holder

Stiftelsen Industrifonden

Instrument

Instrument Ordinary shares
Before the transaction
Shares Data not given*
Voting rights Data not given*
Transaction
Reason for major shareholding notification Share loan
Date 29/01/2019
Limit for number of shares 20 %
Limit for number of votes 20 %
After the transaction
Quantity
Shares 10,420,805
Directly held voting rights 10,420,805
Indirectly held voting rights 0
Percentage
Directly held shares 21.33578 %
Directly held voting rights 21.33578 %
Indirectly held voting rights 0 %

Resulting distribution of total holdings

Percentage of voting
rights:
Number of underlying
shares:
Shares 21.33578 % 10,420,805
Instruments - FITA Ch. 4, section 2, first
paragraph, line 2
Instruments - FITA Ch. 4, section 2,
first paragraph, line 3
- Physically settled
- Cash settled
Total 21.33578 % 10,420,805
Group total holdings

Voting rights 10,420,805 Percentage of voting rights 21.33578

Notes (other relevant informations according to law)

Flaggningen avser återleverans av utlånade aktier i samband med nyemission i Oncopeptides. Flaggningen är baserad på 48 841 921 utestående aktier i Oncopeptides.

Published

30/01/2019 15:25

Contact

Name Jonas Brambeck Phone +46708791937 Email [email protected]

*Source of information has chosen not to submit the data

[email protected] Tfn 08-408 980 37 Fax 08-24 39 25